These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18987143)

  • 41. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor.
    Liu Y; de Waal Malefyt R; Briere F; Parham C; Bridon JM; Banchereau J; Moore KW; Xu J
    J Immunol; 1997 Jan; 158(2):604-13. PubMed ID: 8992974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.
    Aoki Y; Jones KD; Tosato G
    J Hematother Stem Cell Res; 2000 Apr; 9(2):137-45. PubMed ID: 10813527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection.
    Menke DM; Chadbum A; Cesarman E; Green E; Berenson J; Said J; Tiemann M; Parwaresch R; Thome SD
    Am J Clin Pathol; 2002 Feb; 117(2):268-75. PubMed ID: 11863223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus.
    Sun Y; Huang PL; Li JJ; Huang YQ; Zhang L; Huang PL; Lee-Huang S
    Biochem Biophys Res Commun; 2001 Oct; 287(4):983-94. PubMed ID: 11573962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.
    Cannon JS; Nicholas J; Orenstein JM; Mann RB; Murray PG; Browning PJ; DiGiuseppe JA; Cesarman E; Hayward GS; Ambinder RF
    J Infect Dis; 1999 Sep; 180(3):824-8. PubMed ID: 10438372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma.
    Teruya-Feldstein J; Zauber P; Setsuda JE; Berman EL; Sorbara L; Raffeld M; Tosato G; Jaffe ES
    Lab Invest; 1998 Dec; 78(12):1637-42. PubMed ID: 9881964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease.
    Brousset P; Cesarman E; Meggetto F; Lamant L; Delsol G
    Hum Pathol; 2001 Jan; 32(1):95-100. PubMed ID: 11172301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein Barr Virus Interleukin 10 Suppresses Anti-inflammatory Phenotype in Human Monocytes.
    Jog NR; Chakravarty EF; Guthridge JM; James JA
    Front Immunol; 2018; 9():2198. PubMed ID: 30356670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression.
    Chang H; Dittmer DP; Shin YC; Hong Y; Jung JU
    J Virol; 2005 Nov; 79(22):14371-82. PubMed ID: 16254371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion.
    Mori Y; Nishimoto N; Ohno M; Inagi R; Dhepakson P; Amou K; Yoshizaki K; Yamanishi K
    J Med Virol; 2000 Jul; 61(3):332-5. PubMed ID: 10861641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-6 and its receptors: a highly regulated and dynamic system.
    Wolf J; Rose-John S; Garbers C
    Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
    Carbone A; De Paoli P; Gloghini A; Vaccher E
    Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extended lung expression and increased tissue localization of viral IL-10 with adenoviral gene therapy.
    Minter RM; Ferry MA; Rectenwald JE; Bahjat FR; Oberholzer A; Oberholzer C; La Face D; Tsai V; Ahmed CM; Hutchins B; Copeland EM; Ginsberg HS; Moldawer LL
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):277-82. PubMed ID: 11134537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.
    Ciufo DM; Cannon JS; Poole LJ; Wu FY; Murray P; Ambinder RF; Hayward GS
    J Virol; 2001 Jun; 75(12):5614-26. PubMed ID: 11356969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human gammaherpesvirus cytokines and chemokine receptors.
    Nicholas J
    J Interferon Cytokine Res; 2005 Jul; 25(7):373-83. PubMed ID: 16022582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.
    Lu M; Suen J; Frias C; Pfeiffer R; Tsai MH; Chuang E; Zeichner SL
    J Virol; 2004 Dec; 78(24):13637-52. PubMed ID: 15564474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions.
    Aoki Y; Yarchoan R; Braun J; Iwamoto A; Tosato G
    Blood; 2000 Aug; 96(4):1599-601. PubMed ID: 10942415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming.
    Inagaki T; Wang KH; Kumar A; Izumiya C; Miura H; Komaki S; Davis RR; Tepper CG; Katano H; Shimoda M; Izumiya Y
    PLoS Pathog; 2023 Nov; 19(11):e1011771. PubMed ID: 37934757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Virokines in the pathogenesis of cancer: focus on human herpesvirus 8.
    Klouche M; Carruba G; Castagnetta L; Rose-John S
    Ann N Y Acad Sci; 2004 Dec; 1028():329-39. PubMed ID: 15650258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.